Who owns ABIOMED?

Key details on ABIOMED (Ticker: ABMD)

Who owns ABIOMED?

Is ABMD a good stock to own? Find out who bought ABIOMED, who sold ABIOMED (ABMD) stock, and who holds a large position in ABIOMED.

Fund Name Number of Shares Share Valuation As Of
PRIMECAP Management Company 5.66M $405.33M March 31, 2015
Essex Woodlands Health Ventures 3.15M $225.48M March 31, 2015
Vanguard 2.96M $211.87M March 31, 2015
Palo Alto Investors 2.47M $177.06M March 31, 2015
BlackRock Fund Advisors 2.33M $166.94M March 31, 2015
Jackson Square Partners 1.83M $120.22M June 30, 2015
Tiger Global Management 1.69M $41.96M Sept. 30, 2014
Blue Mountain Capital Management 1.61M $41.87M March 31, 2014
William Blair $ Company 1.39M $99.69M March 31, 2015
Wellington Management Company 1.31M $93.87M March 31, 2015
Macquarie 1.22M $87.62M March 31, 2015
Cortina Asset Management 1.06M $26.43M Sept. 30, 2014
Next Century Growth Investors 1.03M $39.21M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 1.01M $72.64M March 31, 2015
Millennium Management 947170 $36.05M Dec. 31, 2014
Allianz Global Investors of America 903050 $20.04M March 31, 2012
Royal Bank of Canada 893266 $34.10M Dec. 31, 2014

Who sold ABIOMED?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbus Circle Investors June 30, 2011 943204 $15.28M
Norges Bank Investment Management March 31, 2011 1.17M $17.02M
Portolan Capital Management March 31, 2011 1.10M $15.92M